Division of Gastroenterology, Washington University School of Medicine, Washington University/Barnes Jewish Hospital, 660 South Euclid #8124, St Louis, MO 63110, USA.
Division of Gastroenterology, Washington University School of Medicine, Washington University, 660 South Euclid #8124, St Louis, MO 63110, USA.
Gastrointest Endosc Clin N Am. 2024 Oct;34(4):743-756. doi: 10.1016/j.giec.2024.06.003. Epub 2024 Aug 16.
The obesity epidemic continues to worsen in the United States with currently 40% of adults with obesity. While lifestyle changes, pharmacologic and surgical treatments are the mainstay of therapy, they often are either inadequate to meet desired weight loss or underutilized due to patient preference. Endoscopic bariatric treatment can fill these gaps. Combination of endoscopic therapy with pharmacologic therapy can help narrow the gap between endoscopic and surgical bariatric treatment, as well as treat weight recidivism, inadequate weight loss, or further improve associated medical comorbidities in patients who have undergone or are undergoing endoscopic bariatric treatment.
美国的肥胖症流行情况持续恶化，目前有 40%的成年人患有肥胖症。尽管生活方式的改变、药物和手术治疗是治疗的主要方法，但它们往往要么不足以满足理想的减肥目标，要么由于患者的偏好而未得到充分利用。内镜减重治疗可以填补这些空白。将内镜治疗与药物治疗相结合，可以帮助缩小内镜和手术减重治疗之间的差距，并治疗减重后复发、减重不足或进一步改善已经接受或正在接受内镜减重治疗的患者的相关合并症。
